
Alembic Pharmaceuticals Ltd
NSE:APLLTD

During the last 3 months Alembic Pharmaceuticals Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 14% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nse/aplltd/vs/indx/bsesn">open performance analysis).
The last transaction was made on
Mar 17, 2022
by
Alembic Limited
(Chairman)
, who
bought
28.5m INR
worth of APLLTD shares.
During the last 3 months Alembic Pharmaceuticals Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 14% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nse/aplltd/vs/indx/bsesn">open performance analysis).
The last transaction was made on
Mar 17, 2022
by
Alembic Limited
(Chairman)
, who
bought
28.5m INR
worth of APLLTD shares.
Alembic Pharmaceuticals Ltd
Glance View
Alembic Pharmaceuticals Ltd., with roots tracing back over a hundred years, began as a modest tincture and alcohol company in Vadodara, India. Its journey from crafting everyday remedies to becoming a stalwart in the pharmaceutical industry exemplifies ambition intertwined with tradition. Today, Alembic stands as a formidable entity, specializing in the research, development, manufacturing, and sale of active pharmaceutical ingredients (APIs) and generic formulations. The company thrives on a blend of innovation and scalability, strategically advancing its manufacturing capabilities while adhering to stringent quality standards. This commitment has not only bolstered its domestic stronghold but also enabled it to penetrate highly regulated international markets, such as the United States and Europe. The company's revenue model is anchored on an extensive portfolio that addresses therapeutic areas ranging from cardiovascular and anti-diabetics to respiratory and anti-infective products. By leveraging its robust R&D infrastructure, Alembic consistently introduces new and complex generics, amplifying its offerings while navigating the generic drug pricing pressures. Their vertically integrated operations ensure cost efficiency and control over API supplies, easing supply chain constraints and fortifying their competitive position. Additionally, strategic partnerships and investments in advanced manufacturing technologies have augmented its capability to meet global demands, cementing Alembic’s reputation as a reliable partner in the pharmaceutical landscape. This multifaceted approach not only expands its business horizons but firmly establishes Alembic as a key player in addressing global healthcare needs.

What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.